Nokia Oyj (NOKBF)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	21,710	23,829	18,679	25,836	35,794	21,696
Market Cap Growth	32.78%	27.57%	-27.70%	-27.82%	64.98%	4.43%
Enterprise Value	20,140	19,639	17,524	21,841	31,873	20,346
Last Close Price	3.97	4.31	3.18	4.28	5.88	3.55
PE Ratio	18.12	18.02	25.41	5.69	19.39	-
PS Ratio	0.96	1.20	0.80	1.02	1.42	0.81
PB Ratio	0.93	1.11	0.82	1.13	1.80	1.41
P/TBV Ratio	1.52	1.63	1.21	1.68	3.05	3.26
P/FCF Ratio	12.48	11.39	25.41	27.69	15.24	13.86
P/OCF Ratio	9.08	9.23	12.83	16.40	11.99	10.08
EV/Sales Ratio	0.91	0.99	0.75	0.86	1.26	0.76
EV/EBITDA Ratio	6.71	6.39	5.53	5.32	10.47	8.64
EV/EBIT Ratio	11.15	8.71	7.95	7.56	15.61	16.37
EV/FCF Ratio	11.58	9.39	23.84	23.41	13.57	12.99
Debt / Equity Ratio	0.21	0.23	0.25	0.26	0.32	0.52
Debt / EBITDA Ratio	1.59	1.49	1.69	1.46	1.96	3.02
Debt / FCF Ratio	2.77	2.36	7.84	6.44	2.74	5.07
Asset Turnover	0.51	0.49	0.51	0.57	0.58	0.58
Inventory Turnover	4.27	4.18	4.16	4.80	5.77	5.28
Quick Ratio	1.15	1.34	1.37	1.27	1.39	1.34
Current Ratio	1.46	1.58	1.66	1.59	1.62	1.55
Return on Equity (ROE)	4.47%	8.27%	3.09%	21.61%	11.02%	-17.98%
Return on Assets (ROA)	2.59%	3.44%	3.01%	4.07%	2.94%	1.69%
Return on Capital (ROIC)	3.91%	5.30%	4.71%	6.74%	5.32%	3.20%
Return on Capital Employed (ROCE)	5.90%	7.80%	6.90%	9.00%	6.40%	4.20%
Earnings Yield	5.52%	5.55%	3.94%	17.58%	5.16%	-14.22%
FCF Yield	8.01%	8.78%	3.94%	3.61%	6.56%	7.22%
Dividend Yield	3.56%	3.36%	4.52%	3.00%	1.55%	-
Payout Ratio	69.02%	55.91%	91.88%	7.91%	0.56%	-
Buyback Yield / Dilution	0.20%	-0.05%	2.07%	0.31%	-1.28%	0.25%
Total Shareholder Return	3.76%	3.31%	6.58%	3.31%	0.27%	0.25%

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.